Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:4-HO-MiPT / A care free psychedelic getaway
2C-I
Experience:40mg - Brothermind and the Forest's Hand
MDA
6-APB
5-MeO-MiPT
Ayahuasca
MDMA
DOC
PRO-LAD
Piracetam
1B-LSD
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Chameleon.jpgChameleon by Anonymous.
1P-LSD
Experience:25mg 3-MeO-PCP - Enhanced film experience
LSA
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
PARGY-LAD
MiPT
JWH-018
Experience:3-MeO-PCP - Extreme psychosis
2C-E
Experience:1050 µg 1cP-LSD - The matrix
3-MMC
4-AcO-MiPT
2C-P
DOI
25C-NBOMe
4-HO-MiPT
2C-D
MDEA
1P-ETH-LAD
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Proscaline
DPT
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:337mg DMT fumarate - A Day With DMT
4-AcO-DiPT
25I-NBOMe
25B-NBOMe
25I-NBOH
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Tree.jpgJapanese Garden by Anonymous
DMT
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:2 tabs DOB - My DOB Nightmare
DiPT
Pregabalin
TMA-2
6-APDB
Mescaline
Experience:1000 Morning Glory seeds - Rediscovering the Self
Bufotenin
ALD-52
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Omberacetam
4-HO-DPT
Experience:250mg DXM - DXM Itch and Trip Report
2C-B-FLY
25D-NBOMe
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Coluracetam
LSD
EPT
Oxiracetam
2C-B
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:120mg - Garden of The Gods
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Βk-2C-B
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Methallylescaline
Pramiracetam
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
THJ-018
Experience:4-AcO-DMT + 200mg Pill
Bromo-DragonFLY
JWH-073
4-AcO-DET
Psilocin
25C-NBOH
4-HO-MET
5-Hydroxytryptophan
25B-NBOH
Ibogaine
Efavirenz
Experience:~150mg MDA(oral) - a case of mistaken identity
MDAI
Experience:1mg 25c-NBOMe - Experiment in my room
4-HO-MPT
GABAergic hallucinogens
5-MeO-DiPT
ΑMT
LSZ
4-HO-DET
2C-T-21
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
2C-T-2
4-HO-EPT
DET
3-MeO-PCE
2C-C
Selective serotonin reuptake inhibitor
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:800 seeds LSA - My First Trip Ever
TMA-6
AL-LAD
DOM
5-MeO-DALT
MiPLA
MET
THJ-2201
25N-NBOMe
Experience:300µg LSD - Togetherness and the Silent Dusk
Phenylpiracetam
4-AcO-MET
2C-T-7
2C-H
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Amanita muscaria
LSM-775
DOB
Experience:4x 200ug tabs - You do not need to understand
Aniracetam
ETH-LAD
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience:BK-2C-B - Various experiences
Cannabis
Enhancement of colour rose.jpgRose by Chelsea Morgan
4-HO-DiPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Memantine
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
MPT
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Psilocybin mushrooms
4-AcO-DMT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Escaline
Allylescaline
4-FA
3C-E

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.